Diagnosis and inflammatory response of patients with candiduria

Mycoses

Volumn 56, Issue 1, 2013, Pages 61-69

  Helbig, S ^a   Achkar, J M ^b   Jain, N ^b,c   Wang, X ^b,c   Gialanella, P ^b,c   Levi, M ^b,c   Fries, B C ^b,c  

^a JACOBI MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Antifungal agents; Candida; Candida spp; Colonisation

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 6;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDURIA; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; DYSURIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FUNGUS CULTURE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; LEUKOCYTURIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINALYSIS; URINE CULTURE; URINE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; MALE; MIDDLE AGED; URINARY TRACT INFECTIONS;

CANDIDA; CANDIDA GLABRATA;

EID: 84871620320     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2012.02201.x     Document Type: Article

References (40)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999; 103: e39.
2. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21: 510-5.
3. Kauffman CA, Vazquez JA, Sobel JD et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30: 14-18.
4. Alvarez-Lerma F, Nolla-Salas J, Leon C et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 2003; 29: 1069-76.
5. Sobel JD. Management of asymptomatic candiduria. Int J Antimicrob Agents 1999; 11: 285-8.
6. Safdar N, Slattery WR, Knasinski V et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 2005; 40: 1413-21.
7. Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: Incidence, molecular diversity, management and outcome. Intensive Care Med 2008; 34: 292-9.
8. Ang BS, Telenti A, King B, Steckelberg JM, Wilson WR. Candidemia from a urinary tract source: Microbiological aspects and clinical significance. Clin Infect Dis 1993; 17: 662-6.
9. Sobel JD, Kauffman CA, McKinsey D et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30: 19-24.
10. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
11. Chen SC, Tong ZS, Lee OC et al. Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis 2008; 27: 201-8.
12. Colodner R, Nuri Y, Chazan B, Raz R. Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. Eur J Clin Microbiol Infect Dis 2008; 27: 301-5.
13. Jain N, Kohli R, Cook E, Gialanella P, Chang T, Fries BC. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 2007; 73: 1697-703.
14. Chen LC, Goldman DL, Doering TL, Pirofski L, Casadevall A. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect Immun 1999; 67: 2218-24.
15. Brown AJ, Odds FC, Gow NA. Infection-related gene expression in Candida albicans. Curr Opin Microbiol 2007; 10: 307-13. Epub 2007/08/21
16. Naglik JR, Rodgers CA, Shirlaw PJ et al. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J Infect Dis 2003; 188: 469-79.
17. Kauffman CA, Fisher JF, Sobel JD, Newman CA. Candida urinary tract infections - diagnosis. Clin Infect Dis 2011; 52(Suppl 6): S452-6. Epub 2011/04/22
18. Ahearn DG, Jannach JR, Roth FJ Jr. Speciation and densities of yeasts in human urine specimens. Sabouraudia 1966; 5: 110-9. Epub 1966/10/01
19. Cope M, Cevallos ME, Cadle RM, Darouiche RO, Musher DM, Trautner BW. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 2009; 48: 1182-8. Epub 2009/03/19
20. Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 2010; 6: e1001042. Epub 2010/09/03
21. Hedges S, Anderson P, Lidin-Janson G, de Man P, Svanborg C. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun 1991; 59: 421-7. Epub 1991/01/01
22. Godaly G, Hang L, Frendeus B, Svanborg C. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol 2000; 165: 5287-94. Epub 2000/10/25
23. de Man P, van Kooten C, Aarden L, Engberg I, Linder H, Svanborg Eden C. Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection. Infect Immun 1989; 57: 3383-8. Epub 1989/11/01
24. Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J Biol Chem 2002; 277: 7412-9. Epub 2001/12/18
25. Manzano-Gayosso P, Hernandez-Hernandez F, Zavala-Velasquez N et al. [Candiduria in type 2 diabetes mellitus patients and its clinical significance. Candida spp. antifungal susceptibility]. Rev Med Inst Mex Seguro Soc 2008; 46: 603-10. Candiduria en pacientes con diabetes mellitus tipo 2. Sensibilidad antifungica in vitro.
26. Hartupee J, Liu C, Novotny M, Li X, Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 2007; 179: 4135-41. Epub 2007/09/06
27. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009; 5: 329-40. Epub 2009/04/22
28. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453: 1051-7. Epub 2008/06/20
29. Hamada S, Umemura M, Shiono T et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol 2008; 181: 3456-63. Epub 2008/08/21
30. Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007; 178: 4466-72. Epub 2007/03/21
31. Umemura M, Yahagi A, Hamada S et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007; 178: 3786-96. Epub 2007/03/07
32. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004; 190: 624-31. Epub 2004/07/10
33. Conti HR, Shen F, Nayyar N et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206: 299-311.
34. Zelante T, Bozza S, De Luca A et al. Th17 cells in the setting of Aspergillus infection and pathology. Med Mycol 2009; 47(Suppl 1): S162-9. Epub 2008/07/09
35. Bozza S, Zelante T, Moretti S et al. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol 2008; 180: 4022-31. Epub 2008/03/07
36. Zelante T, De Luca A, Bonifazi P et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37: 2695-706. Epub 2007/09/28
37. Hamada H, Garcia-Hernandez ML, Reome JB et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 2009; 182: 3469-81. Epub 2009/03/07
38. Sivick KE, Schaller MA, Smith SN, Mobley HL. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J Immunol 2010; 184: 2065-75. Epub 2010/01/20
39. Hollenbach E. To treat or not to treat - critically ill patients with candiduria. Mycoses 2008; 51(Suppl 2): 12-24.
40. Slavin M, Fastenau J, Sukarom I, Mavros P, Crowley S, Gerth WC. Burden of hospitalization of patients with Candida and Aspergillus infections in Australia. Int J Infect Dis 2004; 8: 111-20. Epub 2004/01/21